New strength of Purdue Pharma's pain patch Butrans gets FDA OK

09/25/2013 | Drug Store News

The FDA approved the 15-microgram-per-hour strength of Purdue Pharma's chronic pain patch Butrans, or buprenorphine. The drug, already approved in 20-microgram, 10-microgram and 5-microgram strengths, is indicated for moderate to severe chronic pain requiring a continuous opioid analgesic for an extended period.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA